StocksDBV TechnologiesDBV.PA

DBV.PA

DBV Technologies

10.24 0.36 (3.64%)
Prices By Xignite, in EUR Market Closed
Trade
S
10.24
B
10.28

Overview

Prev Close10.24
Day's Range9.82 - 10.27
52 Week Range2.31 - 13.39
Average Volume (3m)463.92K
1-Year Return7.11%
Beta-0.027
Market Cap562.11M
P/E Ratio
Revenue11.28M
EPS-2.9016
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.731/12/202012/03/202125/05/20216.008.0010.0012.00
Chart times in UTC
Industry Biotechnology
CEO Daniel Tassé
Employees 141

FINANCIAL SUMMARY

For the quarter ended 31/3/2021, DBV Technologies's revenues decreased by NaN and amounted to 0.00. Net income decreased by 192.81% to -24.45M. Net assets decreased by NaN to N/A and EPS decreased from -0.43 to N/A.
DBV.PA's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
N/A
Net Profit Margin
N/A
Operating Margin
-1,240.93%
Return On Investment
-90.96%
03/13
03/15
06/15
03/21
Total Revenue
796.1K
107.52K
0
0
Gross Profit
N/A
-415.49K
0
-1.23M
Operating Income
N/A
-7.77M
-3.18M
N/A
Net Income
N/A
-6.13M
-8.35M
-24.45M